Sanarus Medical Inc. Appoints John F. Howe As Chief Operating And Chief Financial Officer

PLEASANTON, Calif., April 11 /PRNewswire/ -- Sanarus Medical, Inc., a leading developer of minimally invasive medical devices for diagnosing and treating breast disease, announced today that John F. Howe has joined the company as its new Chief Operating and Chief Financial Officer. Mr. Howe brings more than 25 years of financial and operational management experience in the medical device industry to Sanarus Medical.

Since 2002, Mr. Howe had been the Chief Financial Officer for Eunoe, Inc. a venture backed medical device company that focused on the development and clinical testing of a treatment to stop the progression of Alzheimer's disease. Prior to this, from 1999 to 2002, Mr. Howe held the position of Chief Financial Officer for VidaMed, Inc. a publicly traded medical device company specialized in RF energy based urological systems for treating enlarged prostates. Mr. Howe was instrumental in the sale of VidaMed to Medtronic for $326 million in April 22, 2002. In addition Mr. Howe held several other senior level financial and operational positions with Nellcor Puritan Bennett between 1986-1998, and with IVAC Corporation, a subsidiary of Eli Lilly from 1980-1986.

"John brings a wealth of experience to Sanarus, all of which is extremely applicable to our stage as a company and where we believe we are headed," said John Rush, President and Chief Executive Officer. "John's been the senior financial executive in both venture backed and publicly held companies, he has a record of success in fund raising, integration and acquisition transactions, and he brings a breadth of operational experience in manufacturing, service, and quality systems within startup through multinational medical device companies. John's accomplishments in all of these critical areas will be extremely valuable to Sanarus, and I'm delighted to have him join our team," Mr. Rush concluded.

About Sanarus Medical

Sanarus Medical, Inc., headquartered in Pleasanton, California, is dedicated to advancing women's health by providing a full line of minimally invasive products for the diagnosis and treatment of breast disease. The company is founded in innovative proprietary cryo-technologies uniquely designed for breast biopsy, tumor localization and ablation. The Sanarus cryoablation technology enables a safe and effective office-based procedure at reduced cost. This provides an important alternative for women that currently have to undergo an operating room based, surgically intensive procedure. Privately held, Sanarus Medical is funded by leading healthcare venture capital investors, including U.S. Venture Partners, Forward Ventures, Federated Kaufman Funds, Alta Partners, Pequot Ventures, Technology Funding, and CHANNEL Medical Partners. For more information, visit our website at www.sanarus.com.

CONTACT: John Rush President and CEO Sanarus Medical, Inc. +1-925-460-5777 +1-925-989-2020 (mobile) jrush@sanarus.com

CONTACT: John Rush, President and CEO, of Sanarus Medical, Inc.,+1-925-460-5777, or mobile, +1-925-989-2020, or jrush@sanarus.com

Web site: http://www.sanarus.com//